Events & Insights
Articles
How to Build a Cell Therapy CMC Roadmap
Cell therapies that have reached the market are changing lives. The potential to have such an impact drives sponsors to face the...
Perspectives on Cell Therapy Development and Manufacturing from Cell Therapy Leaders
Explore Kincell Bio’s growing collection of articles, webinars, posters, videos, and more, featuring expert insights into the rapidly evolving cell therapy landscape.
Videos
Tomorrow’s Cures Delivered with Uncompromising Quality
Quality is not merely a department at Kincell; it is a mindset that runs from the shop floor to the highest levels...
Articles
Kincell Bio on Why It’s Expanding Its Research Triangle Park Facility at a Time Other Cell Therapy CDMOs are Retracting
For cell therapy programs approaching commercialization, a CDMO’s infrastructure can make or break their timeline. Hear from Kincell Bio’s leadership team on...
Brochure
A Closer Look at Kincell Bio’s RTP Facility Expansion
Get a closer look at our sell sheet for a more detailed overview of Kincell Bio’s RTP facility expansion, including a preview of...
News
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs
Kincell Bio announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class immune tolerance platform based on epigenetically reprogrammed regulatory T...
Ebooks
The Cornerstones of Cell Therapy Excellence
The Cornerstones of Cell Therapy Excellence, explores analytical, process development, quality, and manufacturing approaches that enable sustainable progress from early development through...
Ebooks
Navigating Intensifying Cell Therapy Regulatory Expectations
In our new eBook, Navigating Intensifying Cell Therapy Regulatory Expectations, Kincell Bio’s scientific and executive leadership break down what’s changed, why programs...
News
Kincell Bio Announces Partnership with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases
Kincell Bio announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class immune tolerance platform based on epigenetically reprogrammed regulatory T...
Articles
Aligning Ethics, Industry Practices and Economics to Expand Cell Therapy Patient Access
Cell therapies hold curative potential, yet far too many patients still can’t access them. In many cases, these treatments aren’t pursued by...
Talk to an expert
Turning Cell Therapy Innovation Into Patient Impact
Leveraging our science-first expertise and right-first-time quality, partner with Kincell Bio to advance your cell therapy from concept to commercialization.
"*" indicates required fields